SNB-19170-04200

3 vaccinations 11 coded responses 25 check-ins 11 free-text entries 2 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 112 / NY
Registered: 2021-04-29

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-28
Dose 1 — Pfizer-BioNTech
2021-04-29
Registered in v-safe
2021-04-30
Survey response — days 1–6 daily, dose 1
MedDRA: Unevaluable event — Feeling: Fair · Fatigue or tiredness

Free text: Blunted emotions

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Chills, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-05-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-05-05
Health check-in — day 7, dose 1
Feeling: Good · Diarrhea

Adult check-in
2021-05-12
Survey response — day 14, dose 1
MedDRA: Menstruation delayed, Menstruation irregular — Feeling: Good

Free text: Menstrual irregularity- cycle significantly delayed when always regular before

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Dose 2 — Pfizer-BioNTech
2021-05-19
Survey response — day 0, dose 2
MedDRA: Anxiety — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: mild anxiety

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-05-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-26
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-06-02
Survey response — day 14, dose 2
MedDRA: Anxiety, Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue, anxiety

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-09
Survey response — day 21, dose 2
MedDRA: Fatigue, Menstrual disorder — Feeling: Fair · Be unable to do your normal daily activities

Free text: FatigueMenstrual cycle disruption

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-16
Survey response — day 28, dose 2
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-23
Survey response — day 35, dose 2
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-30
Survey response — day 42, dose 2
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-18
Survey response — 3 months, dose 2
MedDRA: Menstruation delayed, Oligomenorrhoea — Feeling: Good

Free text: Delayed ovulation, long menstrual cycle has been occurring since the first shot

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-11-18
Survey response — 6 months, dose 2
MedDRA: Condition aggravated, Menstrual disorder, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: latent Lyme became active Menstrual cycle disruption

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-19
Call 1 — Left Voicemail
2022-05-22
Dose 3 — Pfizer-BioNTech
2022-08-21
Survey response — 3 months, dose 3
MedDRA: Postural orthostatic tachycardia syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: POTS

MedDRA releases: 2024-11 · check-in free text available
2022-08-21
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-22
Call successful
Participant prefers to complete VAERS report online
2022-08-22
Call successful
Participant prefers to complete VAERS report online
2022-11-22
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2023-05-22
Health check-in — 12 months, dose 3
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-28	Pfizer-BioNTech
2	2021-05-19	Pfizer-BioNTech
3	2022-05-22	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 1

2021-04-30

Systemic reaction (other): Blunted emotions

Release 8 — day 14, dose 1

2021-05-12

Symptoms: Menstrual irregularity- cycle significantly delayed when always regular before

Release 8 — day 0, dose 2

2021-05-19

Systemic reaction (other): mild anxiety

Release 8 — day 14, dose 2

2021-06-02

Symptoms: Fatigue, anxiety

Release 9 — day 21, dose 2

2021-06-09

Symptoms: FatigueMenstrual cycle disruption

Release 9 — day 28, dose 2

2021-06-16

Symptoms: Fatigue

Release 9 — day 35, dose 2

2021-06-23

Symptoms: Fatigue

Release 9 — day 42, dose 2

2021-06-30

Symptoms: fatigue

Release 9 — 3 months, dose 2

2021-08-18

Symptoms: Delayed ovulation, long menstrual cycle has been occurring since the first shot

Release 10 — 6 months, dose 2

2021-11-18

Symptoms: latent Lyme became active Menstrual cycle disruption

Release 12 — 3 months, dose 3

2022-08-21

Symptoms: POTS

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	✓	✓	✓
SD	Condition aggravated	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Menstrual disorder	✓	✓	✓
SD	Menstruation delayed	✓	✓	✓
SD	Menstruation irregular	✓	✓	✓
SD	Oligomenorrhoea	✓	·	✓
SD	Postural orthostatic tachycardia syndrome	·	·	✓
SD	Pre-existing disease	·	·	✓
SRO	Anxiety	✓	✓	✓
SRO	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release